Kristine M. Radomski

Statistics

Publications

Citations

139

H-Index

Active since

1998

Affiliations

University of North Carolina at Chapel Hill(Current)

Kristine M. Radomski is an author at University of North Carolina at Chapel Hill specializing in cancer pharmacology, clinical pharmacology, and pharmacology.

Publications per year

1998–2000

Publications

Population Pharmacokinetics and Pharmacodynamic Modeling of Abacavir (1592U89) from a Dose-Ranging, Double-Blind, Randomized Monotherapy Trial with Human Immunodeficiency Virus-Infected Subjects

S Weller, Kristine M. Radomski, Yu Lou et al. · Antimicrobial Agents and Chemotherapy · 2000 · 71 citations

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan.

William C. Zamboni, Kristine M. Radomski, Wayne L. Furman et al. · PubMed · 2000 · 58 citations

Medicine, Oncology, Pharmacology +14

Phase I trial of a 96 h paclitaxel infusion with filgrastim support in refractory solid tumor patients

Mark A. Socinski, Paul N. Mudd, Kristine M. Radomski et al. · Anti-Cancer Drugs · 1998 · 10 citations

Pharmacy, Oncology, Pharmacokinetics +17

1–3 of 3